By Marie Rosenthal
The debate over the merits of hydroxychloroquine or chloroquine for COVID-19 is raising questions about the responsibilities of pharmacists, who are trying to use good science and data to guide their recommendations, even though not everyone agrees with them.
Are they coming between a doctor and a patient?